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Tasnim Munshib and Ian J. Scowen*b
The creation of salts is a frequently used approach for the modification of physicochemical properties of
an active pharmaceutical ingredient. Despite the frequency of application, there has been little research
into the structural–property relationships of the final material and the nature of the counterion present. This
work reports on five new salts of sulfathiazole and compares the energetics of the intermolecular interac-
tions with variation in the crystal packing motifs.25
30
35
40
45Introduction
Altering the physicochemical properties of drug materials
through manipulation of their solid-state forms has attracted
considerable attention.1 The creation of multi-component
crystals (e.g. co-crystals, salts and solid solutions) is seen as a
highly attractive and adaptable route for the modification of
the physicochemical properties of active pharmaceutical ingre-
dients (APIs)2–4 resulting from structural and electrostatic fac-
tors. Both salts and co-crystals feature a new crystal structures
with defined intermolecular interactions between the two (or
more) components, while a solid solution retains the parent
crystal structure of one component with the second randomly
distributed throughout the crystal lattice. Salts differ from co-
crystals in that pairs of oppositely charged molecular species
are present and in the case of organic salts, this often corre-
sponds to a single proton transfer within the crystal.
The creation of such materials is now common and, in sev-
eral cases, the new phases have been shown alterations of
properties such as solubility, stability and process perfor-
mance (e.g. tableting).5–10 Furthermore, utility of multi-
component approaches has been demonstrated in cases using
co-crystallisation as a purification step.11,12 However, the de-
sign and selection of components and crystal forms is still of-
ten undertaken through trial and error or serendipitous study.50
55Designing for a pre-defined change in physical properties,
such as creating a new phase with a specific solubility, is still
beyond the state of the art within the field. Many studies have
focused on developing ‘design’ rules to predict how changes
in molecular structure of the component can influence co-
crystallisation.13–16 It has been shown that successful forma-
tion may be predicted by consideration of the interactions be-
tween the components,17 that the nature of the substituent
groups can alter the ability to form co-crystals.14,18 In contrast
comparable studies for salt formers are more unusual and
while proton transfer can related to both chemical and crys-
tallographic structure in certain systems,19 few studies investi-
gating the interaction between molecular structures, inter-
molecular interactions and formation have been presented.
Systematic examples altering the counterions have been
reported for ephedrine,20–22 tyramine,23 gemfibrozil,
flurbiprofen, ibuprofen and etodolac salts24 and studies into
series of sulfonic acid salts have also emerged.25 Unlike co-
crystals, salts feature an additional set of unidirectional
electrostatic interactions between the charged species (both
repulsive and attractive) in addition to the crystal packing
directing interactions. Understanding the balance between
the numerous potential interactions is required to design
such functional materials. Alteration of the key interactions
between the components within a salt by, for example, chang-
ing the nature of the counterion (and its ability to hydrogen
bond, form common motifs and intervene in the hydrogen
patterns of the analogous molecular systems) will directly in-
fluence the lattice energy of the final phase and so the physi-
cochemical properties of the new phase. Given the non-
directional nature of electrostatic interactions, and their influ-
ence over long-ranges, investigating the relative importance of
such interactions in the context of other intermolecular forces
requires relatively sophisticated computational evaluations.tEngComm, 2018, 00, 1–7 | 1
Table 2 Previously published STZ salts with basesa
BUHMOI
DOWPUC
DOWQAJ
HSLSTZ
OHUWAR
OHUWEV
OHUWIZ
OEDWAZ
XIFPEI
a Results from a CSD search as detailed before. Protonated and
deprotonated forms of each tautomer were searched.
Fig. 1 Molecular structures of STZ showing tautomerism and potential
salt forms.
Table 1 Previously published STZ salts with acidsa
REFCODE Chemical structure
BUWDUT
KUFWIT
LOFMAW
(polymorphic)
UDAKOA
a Results from a CSD search as detailed before. Protonated and
deprotonated forms of each tautomer were searched.
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the assembly of salt-forms. Recently computational studies
have indicated that the central role of directing hydrogen
bonding in the analysis and design of organic materials has
been overemphasised26 and calculation of interaction ener-
gies between the molecular species is required to fully under-
stand the assembly of the crystal structure.
Sulfathiazole (STZ) is well established as a studied model
active pharmaceutical ingredient (API) and its five polymor-
phic forms have been extensively considered.27 There are a
plethora of multi-component crystals formed including over
one hundred solvates,28 however, published crystal structures
are only available for thirteen co-crystals (Table S2†).‡ The
molecule can undergo tautomerism and capable of forming
salts with either acids or bases (Fig. 1). Previous studies into
STZ salts are also limited to four systems with STZ acting as
a base and nine where it acts as an acid (Tables 1 and 2).
This range of structural flexibility means that STZ offers an
interesting material for further study to identify the role of2 | CrystEngComm, 2018, 00, 1–7
‡ Cambridge structure database (CSD) version 5.37 with 3 updates was searched
using Conquest 1.18 for systems containing either tautomer. Only organic sys-
tems were included.different structural factors and intermolecular interactions
on solid formation. To this end, salt formation between STZ
and nitric acid (I), tetrafluoroboric acid (II), sulfuric acid (III),
hydrochloric acid (IV), benzenesulfonic acid (V) and toluene-
sulfonic acid (VI) (Scheme 1) was investigated to identify how
the crystal structure motifs are altered by variation of the
components of the salt. The energetics of the new systems
alongside those identified in the CSD were studied to identifyThis journal is © The Royal Society of Chemistry 2018
Scheme 1 Chemical structures of counterions used in this study.
55
Fig. 3 Formation of a 2-D sheet in II through NH⋯N and NH⋯F
bonds.
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ence the lattice characteristics (energy and structure) of
ionised components in these organic salts.
Methodology
Experimental
Crystallisation. Sulfathiazole salts were prepared by
adding the appropriate acid (1 mmol) to a solution of
sulfathiazole (1 mmol) in either methanol or acetone (4 cm3).
The solutions were filtered to obtain clear solutions and then
slow evaporation of the solvent was allowed to promote crys-
tal growth. Single crystals suitable for crystal structure analy-
sis were obtained for I, II, III, V and VI, while PXRD on the
powders obtained for IV indicated a new crystal phase, suc-
cessful growth of suitable crystal was not achieved for IV.
Single crystal structure determination. The crystallo-
graphic details for all systems are given in Table S1.† The
data was collected on a Bruker X8 Apex II diffractometer
using graphite monochromated Mo Kα radiation at 173 K.
The data was collected and reduced using Bruker SMART
software. The structures of I, II and III were solved and re-
fined using SHELXTL, whereas the structures of V and VI
were solved and refined in Olex2 (ref. 29) using SHELXT and
SHELXL.30 The structure of VI revealed the presence of a
channel containing disordered solvent; this was modelled
using squeeze methodology in Platon.31 The resulting struc-
ture files have been deposited with Cambridge Crystallo-
graphic Data Centre (CCDC 1499236–1499240).
Computational
Lattice energies. The hydrogen locations in all crystal
structures were normalised and the lattice energies of
resulting structures minimised using Forcite in the Materials
Studio package. Given the wide range of atom types in the
salts considered, a limited number of force fields were avail-
able for the energy calculations. Lattice energies were calcu-
lated using the Universal force field32,33 with atomic point
charges derived for each molecule by fitting to the electro-
static potential calculated from a DFT calculation (TPSS-D3/
def2-TZVPPD)34–36 in the program orca,37 for all systems,
while AA-CLP force field38 was also used for selected systems.This journal is © The Royal Society of Chemistry 2018
Fig. 2 Formation of bilayer structure in I between STZH+ and NO3/
HNO3 ions.
45In this case, the crystal structures were optimised by downhill
simplex method with fixed unit cell parameters. For III, V
and BUWDUT, the disordered crystal structures were
converted to ordered models in lower symmetries. In the case
of III and V, the unit cells were initially reduced to P1 sym-
metry, half of the disordered components were removed and
additional symmetry identified by ADDSYM program in
Platon to give a Z′ = 1 structure in P21/c (III) and a Z′ = 2
structure in Pna21 (V). For BUWDUT, half the disordered
components were removed and the symmetry reduced to P1¯.
Molecular clusters. Dimers and higher molecular clusters
were extracted from the relevant crystal structure and the hy-
drogen atom locations optimised in the program orca (TPSS-
D3/TZVĲd) (main group) TZV (hydrogen)).39,40 The binding en-
ergies were then calculated at the TPSS-D3/def2-TZVPPD level
of theory with the basis set superposition error corrected for
by the counterpoise method of Boys and Bernardi.41
Results and discussion
Crystal structure analysis
Salt I is shown to be a hydrogen nitrate salt (NO3/HNO3). The
STZH+ molecules link into a 1-D chain with a NO3/HNO3 pair
bridging the two chains through NH⋯O bonds to forming a
bilayer structure (Fig. 2). These 2-D layers then link to form
the final 3-D structure through weaker CH⋯OS
interactions.
Salt II forms a 1 : 1 salt with BF4
−, which produces a 1-D
chain between STZH+ cations through N–H⋯N hydrogen
bonds, with the BF4
− anion bonding through N–H⋯F interac-
tions to form a 2-D sheet structure (Fig. 3). The final 3-D
structure is formed through NH⋯OS hydrogen bonds.CrystEngComm, 2018, 00, 1–7 | 3
Fig. 4 Formation of a 1-D chain between STZ/HSO4
−/OH− groups in
III.
50
55
Scheme 2 Formation of aldol product (VI) with sulfathiazole and
toluenesulfonic acid.
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STZ, a single sulfate ion and an isolated oxygen atom present
in the asymmetric cell. However, the disorder in the structure
makes it hard to clearly identify all the hydrogen atoms and
resolve the system as either HSO4
−/OH− or SO4
2−/H2O. The
S–O bond lengths in the sulfate group are characteristic of a
HSO4
− anion (three ∼1.45 Å and one ∼1.55 Å). The distance
from the isolated oxygen to the oxygen in the sulfate group is
very short (1.8 Å) and so a central shared hydrogen present
between the groups is possible. The crystal structure of III is
isostructural to that of BUWDUT. The STZ cations hydrogen
bond into a dimer through +NH⋯Nhydrogen bonds, which
then form a 1-D chain through NH⋯O hydrogen bonds with
the HSO4
−/OH− cluster (Fig. 4). The final 3-D structure is
constructed through the interlinking of these chains.
Salt V formed with benzenesulfonate has a 1 : 1 composi-
tion and the crystal structure displays an orientation disorder
in the aromatic component with a 50 : 50% split. The two
components are hydrogen bonded together through
NH⋯OS hydrogen bonds to form two ring motifs, one a
R44(12) motif formed by two benzenesulfonate SO3 groups
bridging two NH3
+ group on STZ (Fig. 5a), while the second
is a R44(28) motif which binds four molecules through Nring–
H⋯OS and NH3+⋯OS bonds (Fig. 5b). The combination
of these motifs form a 2-D sheet structure in the crystal,
which are packed into the final 3-D structure through
CH⋯OS interactions.
Crystal structure determination of VI confirmed that STZ
had undergone an acid catalysed aldol reaction with the ace-
tone solvent (Scheme 2). The resulting product forms a salt
with the toluenesulfonic acid. Attempts to crystallise from
other solvents resulted in poor quality crystals and attempts4 | CrystEngComm, 2018, 00, 1–7
Fig. 5 Formation of tetramers in the crystal structure of V, (a) R44(12)
motif and (b) R44(28) motif. Only one component of disordered
benzenesulfonate counterion is shown and selected hydrogens
removed for clarity.
35to determine a structure for STZ with toluenesulfonate were
unsuccessful. Strong +NH⋯−OS hydrogen bonds between
the two components of the salt, forms a 1-D channel which is
filled with disordered solvent (Fig. 6). The channel void space
is calculated to be 277 Å3 (10% of unit cell volume) and runs
through the entire crystal structure along the b-axis. These
channels are linked through weaker CH⋯O bonds to con-
struct the final crystal structure.
Comparison of crystal structures
Analysis of the crystal packing of the structures present in
the CSD is given in the ESI.† While all the known STZ poly-
morphs form dimers between the STZ molecules, dimer for-
mation only occurs in three salts (BUWDUT, KUFWIT and III)
that display different hydrogen bonding to each other and
the polymorphs. While a repulsion between the positively
charged STZ ions would be expected, the relative isolation of
the charged species at one end of the relative large compo-
nent the sum of other interactions may be larger enough to
overcome the repulsion. Thus, the interaction energies were
quantified for the various crystals and molecular
components.
Computational studies
Lattice energies for the STZ salts were calculated using two
force fields (Table 3) that give different ordering of the crystal
structures. However, in both cases the lowest energy systemsThis journal is © The Royal Society of Chemistry 2018
Fig. 6 Formation of channel structure in VI.
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Table 4 Binding energies of key motifs in STZ salts crystal structures
System STZH+/anion energy (kJ mol−1) STZH+/STZH+ energy (kJ mol−1) Anion/anion energy (kJ mol−1)
BUWDUT (SiF6
2−) −700.17 45.72 964.05
LOFMAW01 (hydrogen oxalate) −462.85 154.25 156.30
UDAKOA (NO3
−/H2O) −434.76 121.34 252.72
II (BF4
−) −430.83 110.98 313.56
I (NO3
−/HNO3) −362.81 115.28 343.08
V (benzenesulfonate) −289.98 107.22 422.25
LOFMAW (hydrogen oxalate) −250.80 125.82 221.86
KUFWIT (2,4-dinitrobenzoate) −203.88 5.91 229.05
III (HSO4/H2O)
a −94.37 57.86 939.97
a After hydrogen position optimisation, the cation⋯anion system had rearranged to give a trimer with a HSO4, H2O and a neutral STZ. Anion
pairs calculated for SO4
2− system.
Table 3 Calculated lattice energies of STZ salts (sorted by AA-CLP energies)
System Universal force field lattice energy (kJ mol−1) AA-CLP lattice energy (kJ mol−1)
BUWDUT (SiF6
2−) −917.57 −739.73
III (SO4
2−/H2O) −765.86 −523.15
III (HSO4
−/OH−) −444.8 −484.25
V (benzenesulfonate) −232.23 −417.65
I (NO3
−/HNO3) −165.03 −403.11
KUFWIT (2,4-dinitrobenzoate/2,4-dinitrobenzoic acid) −544.1 −288.562
LOFMAW (hydrogen oxalate) −579.1 −254.372
LOFMAW01 (hydrogen oxalate) −517.15 −239.478
UDAKOA (NO3
−/H2O) −209.58 −209.97
II (BF4
−) −313.69 −184.91
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counterion (SiF6
2− and SO4
2−). Alteration of the hydrogen loca-
tion for III (from SO4
2− to HSO4
−) alters the absolute energy of
the system but not the relative position in either list. Both
these structures are isostructural and so geometrical and
electrostatic interactions appear to be dominant in this case.
The systems with specific hydrogen bonds between the com-
ponents have lower lattice energies suggesting that comple-
mentary design of hydrogen bonding with electrostatic and
geometric factors could be a key factor in the creation of high
stability phases.Fig. 7 Hydrogen position optimised STZH+/STZ+ dimers in (a)
BUWDUT, (b) III, (c) KUFWIT (d) V, (e) I, (f) UDAKOA, (g) LOFMAW, (h)
LOFMAW01 and (i) II.
40
45
50
55Molecular dimers
The energies of closest pairs of STZH+/STZH+, STZH+/anion
and anion/anion ions from each crystal structure were calcu-
lated for the geometry in the crystal structure (Table 4,
Fig. 7–9). As expected the electrostatic contribution domi-
nates the energetics, with attractive forces between the anion
and cation and repulsive forces in the cation/cation and an-
ion/anion pairs. Dimers between STZH+ ions are present in
III, BUWDUT and KUFWIT. In III and BUWDUT are linked
through two NH⋯N hydrogen bonds, while KUFWIT utilises
two NH⋯OS bonds. In both cases the energy gained by the
interactions offsets the repulsive energy of the electrostatic
interaction within the dimer. However, during the hydrogen
location optimisation for III cation/anion pair, significant
rearrangement of the hydrogen atoms took place resulting in
a neutral STZ molecule, which gives a significantly lower en-This journal is © The Royal Society of Chemistry 2018ergy. The remaining systems have a single hydrogen bond be-
tween the STZH+ ions forming a 1-D chain motif in each
case; this does not shield repulsive interaction as effectively.
The difference in binding energy for the two polymorphs of
the oxalate appears to be driven by the different conforma-
tions of the oxalate anion. In form I, an intramolecular hy-
drogen bond stabilises that form by 41.33 kJ mol−1.
The polymorphs of pure STZ display dimers in forms I–IV
and a tetramer in form V. The hydrogen bonding in form I
differs from forms II–IV as it contains a R22(8) motif formed
by NH⋯N bonds, while the other, has a mix of NH⋯N andCrystEngComm, 2018, 00, 1–7 | 5
Fig. 10 Comparison of the molecular motifs in (a) form I, (b) forms II–
IV and (c) form V STZ.
Fig. 8 Hydrogen position optimised anion/STZ dimers in (a) II, (b)
UDAKOA, (c) I, (d) V, (e) BUWDUT, (f) LOFMAW01, (g) KUFWIT, (h)
LOFMAW and (i) III.
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lowest energy (Table 5), however it is present in the stable
phases of STZ and is not similar to the motifs present in the
salts determined. Importantly, these H-bonded motifs all cor-
respond with attractive STZ⋯STZ interaction in the lattice.
As expected, the STZ⋯STZ interactions in the salts change
to repulsive in the crystal lattice (Table 2). Three distinct
groupings arise from considering the repulsions: (i) <50 kJ
mol−1 [III, BEWDUT and KUFWIT], (ii) 100–125 kJ mol−1 [I, II,
V, UDAKOA, LOFMAW], (iii) >150 kJ mol−1 [LOFMAW01]. It
might be helpful in this context to view the salts as arrays of
repulsive cations, whose repulsive interactions are mediated
by the counterions. Broadly, it appears that interactions be-
tween the anion centres and the protonated amine (the centre
of cationic charge), exerts a considerable influence in mediat-
ing the STZ⋯STZ repulsion. Intriguingly, these correlate with
the relative dispositions of the protonated aniline centre of
adjacent STZH+ units in the crystal structure and the numbers
of anions in the local vicinity: for grouping (i), the STZH+ sys-
tems are arranged in a head-to-tail orientation an each have
two anions in close contact with each anilinyl (–NH3
+) centre –
the remaining interaction to SO and/or S–N of an adjacent6 | CrystEngComm, 2018, 00, 1–7
Fig. 9 Hydrogen position optimised anion/anion pairs in (a) LOFMAW,
(b) LOFMAW01, (c) KUFWIT, (d) V, (e) UDAKOA, (f) I, (g) II, (h) BUWDUT
and (i) III.
40
45STZH+. For group (ii), the layered structures have a STZH+ sys-
tem in a head-to-tail orientation, but only one close contact
with the counterion is observed (again remaining interactions
at the NH3
+ arise from SO/S–N or HN). For (iii), the
LOFMAW01 outlier has close contacts to an oxH⋯oxH centro-
symmetric dimer that brings the adjacent STZH+ molecules
together in a ‘head to-head’ orientation. Overall, it appears
that increasing the number of anions surrounding the cation
centre and their charge density effectively screens the repul-
sion between adjacent cations. Clearly this repulsion is
maximised in the ‘head-to-head’ configuration. Similarly, the
converse also appears to be true. Bringing charge dense anion
centres into close proximity (III and BUWDUT), causes very
large relative anion anion repulsions in excess of 600 kJ mol−1
compared to the more distal anions. While such ‘charge-
balance’ concepts may prove valuable in unpicking the rela-
tive influences, it is the interplay of the relative cation–anion
attractions, and cation–cation/anion–anion repulsions thatThis journal is © The Royal Society of Chemistry 2018
Table 5 Energies for STZ polymorphs key motifs
Polymorph
STZ⋯STZ energy
(kJ mol−1)
Energy per molecule
(kJ mol−1)
Form I dimer −109.42 −54.71
Form II/III/IV dimer −41.49 −20.75
Form V tetramer −143.29 −35.82
50
55
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Importantly, H-bonded motifs may considerably have less in-
fluence in ionised systems in the solid state.
Conclusions
These studies have established an important approach to un-
derstanding the relative importance of intermolecular inter-
actions in salts of pharmaceutical products, through a combi-
nation of systematic experimentation (complimenting
database structures) and computational analysis of the lattice
energies of the resulting crystal structures. It appears from
this study that converting molecular species with potential to
form diverse hydrogen bonding motifs in the solid to their
analogous salt forms switches the intermolecular interaction
from attraction to overall repulsion. Furthermore, the media-
tion of repulsion between charged centres with judicious
choice of anion to ‘screen’ the repulsions between adjacent
molecules, offers a route to influence lattice energy and
hence the crystal packing of pharmaceutical ingredients.
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